Avner Lushi - Aug 15, 2024 Form 3 Insider Report for Biomotion Sciences (SLXN)

Role: Director, 10%+ Owner
Signature: /s/ Mirit Horenshtein-Hadar, as attorney for Avner Lushi
Stock symbol: SLXN
Transactions as of: Aug 15, 2024
Transactions value $: $0
Form type: 3
Date filed: 8/15/2024, 07:38 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SLXN	Ordinary Shares						1.99M	Aug 15, 2024	By Guangzhou Sino-Israel Biotech Fund	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line as a result of his serving as a Managing Partner and CEO of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein.

Content

The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line as a result of his serving as a Managing Partner and CEO of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein.

Remarks:

Exhibit 24.1 Power of Attorney